Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.02.2017 | Case report

Cisplatin/etoposide/ifosfamide

Encephalopathy successfully treated with thiamine: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Langebrake C, et al. Successful treatment and prevention of cisplatin/etoposide induced encephalopathy with thiamine. European Journal of Hospital Pharmacy - Science and Practice 23 (Suppl. 1): A153 abstr. DI-080, Mar 2016. Available from: URL: http://doi.org/10.1136/ejhpharm-2016-000875.346 [abstract] -Germany Langebrake C, et al. Successful treatment and prevention of cisplatin/etoposide induced encephalopathy with thiamine. European Journal of Hospital Pharmacy - Science and Practice 23 (Suppl. 1): A153 abstr. DI-080, Mar 2016. Available from: URL: http://​doi.​org/​10.​1136/​ejhpharm-2016-000875.​346 [abstract] -Germany
Metadaten
Titel
Cisplatin/etoposide/ifosfamide
Encephalopathy successfully treated with thiamine: case report
Publikationsdatum
01.02.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-26654-7

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Cyproterone

Case report

Eltrombopag

Case report

Lorazepam

Case report

Doxorubicin